Nanobiotix
Nanobiotix is a nanomedicine company developing novel therapeutics for the local treatment of cancer.
Nanobiotix has raised €13M across 2 funding rounds from 2 investors, most recently a round in Jul 2013. Based in Paris, France; founded 2007; active in Healthtech. Data as of 28 Oct 2026.
Total raised
€13M
€12,700,000
Funding rounds
2
Investors
2
distinct backers
Active since
2010-05
latest 2013-07
Funding by year
EUR raised per yearNanobiotix — funding by year — interactive chart.
Data table
| Nanobiotix — funding by year | |
|---|---|
| 2010 | €9.9M |
| 2013 | €2.8M |
Signals
High confidenceRaise-next likelihood5
base rate 30% for Other
- ▼ Dormant (no round in 3+ cohort gaps)
- ▼ Down/flat last round
- ▼ Low backer re-investment
Exit likelihood5
base rate 11% (2+ rounds)
- ▼ Old (19y) — past typical exit age
- ▼ No recent equity round (debt-only or quiet)
Timing: dormant vs cohort gap · momentum down. Funding-only estimates, not predictions and not investment advice — see signals.
Funding rounds
2 rounds| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2013-07-01 | Other | €2.8M | Bpifrance | View deal → |
| 2010-05-01 | Other | €9.9M | Seventure Partners | View deal → |
Investors
2Similar companies
same sector or country- Mistral AI€6.5BFrance · AI
- Automotive Cells Company (ACC)€4.4BFrance · Transportation
- Philips€2.6BNetherlands · Healthtech
- Verkor€2.4BFrance · Energy
- Isomorphic Labs€2.3BUK · Healthtech
- CMR Surgical€1.5BUK · Healthtech
Global coverage: FundingData